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Background: Schistosomiasis and soil-transmitted helminths (STH) infections are major public health pro-
blems. We aimed to study the 6-mo impact of mass drug administration with praziquantel and albendazole
on urinary schistosomiasis and STH.
Methods: We examined children (aged 2–15 y) from one hamlet, who provided urine and faeces samples at
baseline (n=197), 1 mo (n=102) and 6 mo (n=92); 67 completed the protocol.
Results: At baseline, 47/67 (70.1%) children presented Schistosoma haematobium (75.8% in the baseline total
sample) and 12/67 (17.9%) with STH (30.5% in the initial sample, p=0.010). Among the children, 47.3% had
heavy Schistosoma haematobium infection. The most frequent STH was Trichuris trichiura in 9.0%. We also
found Hymenolepis nana (13.2%) and Plasmodium falciparum (9.1%) infections and anaemia (82.1%). One
mo after chemotherapy there was a signiﬁcant (p=0.013) reduction of Schistosoma haematobium prevalence
(23.5%) and a high egg reduction rate (86.9%). Considering the sample of 67 children, the mean egg concen-
tration was 498 at baseline, 65 at 1 mo and 252 at 6 mo (p<0.05). We also observed a reduction in STH infec-
tions, 50% in Ascaris lumbricoides, 33.3% in T. trichiura and 50% in hookworms. At 6 mo, the prevalence of
Schistosoma haematobium (76.1%) was similar to the baseline and the STH reduction was not signiﬁcant.
Conclusions: Longitudinal studies have reported many losses in these settings, but we were able to show that
mass drug administration for control of schistosomiasis and STH present low effectiveness, that reinfections
occur rapidly and that stand alone anthelmintic therapy is not a sustainable choice.
Keywords: chemotherapy, mass drug administration, Schistosomiasis haematobia, soil-transmitted helminths
Introduction
Helminth infections have a massive impact on the morbidity
and mortality of human populations globally.1 Schistosoma hae-
matobium, Ascaris lumbricoides, Trichiura trichuris and hook-
worm infections affect 290.6, 804.4, 477.4 and 471.8 million
people worldwide, respectively.2 These infections are endemic in
Angola, where the prevalence of Schistosoma haematobium,
hookworms, A. lumbricoides, T. trichiura and Hymenolepis nana
were reported to be high (10–17, 4–6.7, 15–17, 7–14 and 6–7%,
respectively) in preschool and school-age children in the Dande
municipality (Bengo province, Angola) in 2010.3 Additionally,
some of those species also share their geographical distribution
with malaria, and therefore co-infections were reported. Among
comorbidities associated with these infections, we ﬁnd bladder
and kidney pathologies, chronic inﬂammation, respiratory and
gastrointestinal problems, chronic blood loss, immunity and
anaemia.1,4–9
In Angola, it is expected that there will be adoption of inte-
grated therapeutic mass drug distribution of praziquantel and
albendazole in deworming campaigns, as described in the
National Sanitary Development Plan for 2012–2025 (approved
by Angolan Ministry of Health in 2012). However, research into
the impact of an integrated approach is urgently needed, as it
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could help to clarify key aspects such as behavioural change
related to health education, clean water provision, environmen-
tal sanitation and programme control adherence, which would
help to improve these interventions.
Here, we investigated the 6-mo impact of a community-
based integrated therapeutic intervention with praziquantel,
albendazole and Coartem (if tested positive for malaria), in the
reinfection of schistosomiasis, geohelminths and malaria and in
the occurrence of anaemia.
Materials and methods
Study site
We conducted this investigation in Cabungo, one hamlet of the
study area of Centro de Investigação em Saúde de Angola (CISA),
located in the Dande municipality (Bengo, northern Angola). The
structure, dynamics and geographical distribution of the popula-
tion of this area are monitored by the Health and Demographic
Surveillance System, previously described by Costa and cowor-
kers.10 The initial list provided by Demographic Health Survey con-
sisted of 824 inhabitants, including 364 children aged 2–15 y. The
research team integrated two DHS technicians and updated the
list of children during the baseline, identifying 209 (57.4%) chil-
dren present, who were all invited and participated in the study.
Study design, participants and data collection
This was an interventive prospective study, conducted between
December 2012 and December 2013. Cabungo was selected by
convenience, based on the high rates of schistosomiasis.4 On
the ﬁrst day of the baseline, the study team went from house
to house to identify and invite children aged 2–15 y and to dis-
tribute containers for sample faeces. On the second day, the
population was concentrated in a designated place for a previ-
ously arranged community meeting, where we collected all
urine, faeces and blood samples, applied the questionnaire with
signed consent and administered the drugs. During the two
follow-ups, we met participants at the same designated place.
Six mo after the second follow-up, the team returned to the
participants’ homes to inquire about reasons for non-
adherence. Trained ﬁeld workers conducted the questionnaire to
obtain demographic and socioeconomic data and child morbid-
ity history. We provided a container (1 d prior to survey) to col-
lect one faecal sample per participant while urine samples were
collected in containers provided to participants upon arrival on
the survey day. Both samples were stored in ice at 4°C until
transportation to the CISA laboratory where they were refriger-
ated. Kato-Katz smears were performed by CISA expert techni-
cians for the diagnosis of Schistosoma mansoni, soil-transmitted
helminths (STH) (such as hookworms, A. lumbricoides and T. tri-
chiuria), H. nana and Taenia spp. Urogenital schistosomiasis
(Schistosoma haematobium) was diagnosed by examination of
the pellet resulting from 10 ml centrifuged urine and eggs
count, according to WHO protocol.11 We were not able to use
the membrane for ﬁltration method in this project; however, the
local availability of equipment and laboratory technicians
ensured good execution of the centrifugation method, whose
effectiveness in concentrating the eggs does not cause any
morphological changes to either the helminth eggs or larvae.12
Capillary blood samples were collected for diagnosis of malaria
by rapid diagnostic test (SD BIOLINE Malaria Ag P.f/P.v, Standard
Diagnostics Inc.) and for measurement of haemoglobin levels
with the HemoCue system (HemoCue 201+, Angelholm,
Sweden). All children took a single dose of praziquantel (40 mg/
kg) and albendazole (400 mg) under direct observation at the
ﬁrst visit and 6 mo later. The children who tested positive for
Plasmodium falciparum were treated with Coartem (artemether/
lumefantrine 20/120), in accordance with the national thera-
peutic guidelines for uncomplicated malaria at all evaluation
time points. The national malaria control programme recom-
mends treatment for asymptomatic individuals (human reser-
voirs) with positive Rapid Diagnostic Test (RDT) for plasmodium
at all opportunities, in order to reduce continuous transmission
by the mosquito bite.13,14 In addition, one long-lasting insecti-
cide-treated bednet was provided for each child who partici-
pated in this study. Follow-up visits occurred 1 and 6 mo after
initial drug delivery and parasitological examination. Malaria
treatment was performed on all visits.
Reasons for dropout were investigated performing an add-
itional structured questionnaire, performed 6 mo after the
second follow-up with the same respondents. In these ques-
tionnaires we also asked respondents for suggestions of possible
solutions to improve adherence.
Table 1. Cut-offs for intensity of infection and thresholds used to deﬁne anaemia
Infections Light Moderate Heavy
Schistosoma haematobium (no. of eggs/10 ml of urine) 1–49 ≥50
A. lumbricoides (no. of eggs/gram of faeces) 1–4999 5000–49 999 ≥50 000
T. trichiura (no. of eggs/gram of faeces) 1–999 1000–9999 ≥10 000
Hookworms (no. of eggs/gram of faeces) 1–1999 2000–3999 ≥4000
H. nana (no. of eggs/gram of faeces) 1–1999 2000–9999 ≥10 000
Anaemia in children (g/dl) Mild Moderate Severe
<5 y 9.0–11.0 7.0–8.9 <7
5–11 y 11.0–11.4 8.0–10.9 <8
12–14 y 11.0–11.4 8.0–10.9 <8
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Statistical analysis
Data were entered into the CISA database and then exported to
SPSS Statistics for Windows version 20.0 and R version 3.0.1
(IBM, Armonk, NY, USA). Analyses were performed to determine
prevalence and intensity reduction, intensity and reinfection
rates resulting from Schistosoma haematobium, geohelminths
and H. nana infections, 1 and 6 mo after treatment.
Prevalences were calculated as the frequencies of the outcome
over the total samples with valid results. The intensity of
Schistosoma haematobium infections and of intestinal parasites
was recorded according to WHO15 (Table 1). Also, the age-speciﬁc
severity of anaemia was deﬁned as recommended by WHO.16,17
The prevalence reduction rate (PRR) was calculated as:
−
⁎
% prevalence before the treatment
% prevalence after the treatment
% prevalence before treatment
100
The intensity reduction rate (IRR) was calculated as:
−
⁎
Geometric mean of eggs before the treatment
geometric mean eggs after the treatment
geometric mean before the treatment
100
The post-treatment reinfection rates were calculated as:
⁎Number of children who became positive after the treatment
Number of children who turned negative after the treatment
100
χ2 McNemar’s, paired sample t and Wilcoxon related samples
tests were used to compare difference in the prevalence and
intensity of infections. The threshold for signiﬁcant level was 0.05.
Ethical aspects
This study was approved by the Ethical Committee of the
Ministry of Health of Angola. Informed consent was obtained by
signature from the parents or guardians of children.
Schistosomiasis, geohelminth and malaria infections were trea-
ted. Children with anaemia were referred to the nearest health-
care centre. The project team at the study site provided
education sessions for all people present and returned the
results of parasitological examinations to the parents and guar-
dians of the children who participated in the study.
Results
In this study, we enrolled 209 children (110 boys and 99 girls
aged 2–15 y, with a median age of 6 y). Those who showed no
compliance to drug therapy at the baseline, failed to provide
urine, faeces and blood samples, or had invalid data or examin-
ation results and refused to repeat the procedure, were excluded
from the analysis. Most of these dropouts were children who cried,
vomited or choked upon medication. Some did not give urine or
stool samples and their parents or guardians did not bring them
back to repeat the procedure. Others were absent from the resi-
dences during the study period. Exclusions, dropouts and the
number of followed children are presented in Table 2.
In total, 142 lost to follow-up were questioned concerning
the reasons for their absence at the evaluation time points. The
main reported reason for lost to follow-up was spending school
holidays in the capital for the Christmas vacation (33.1%, 47/
142) and quarterly break (21.8%, 31/142). The other reasons
were the side effects of medication reported by participants
(16.2%, 23/142 and 11.3%, 16/142) and the unavailability of
the caregiver to take the child to the evaluation (4.2%, 6/142
and 5.6%, 8/142) during the ﬁrst and second evaluations,
respectively.
About 100 respondents suggested possible solutions to
improve adherence, including family counselling regarding sani-
tation and hygiene (45%, 45/100) and door-to-door notiﬁcation
of the follow-up dates (29%, 29/100).
Children within the lost to follow-up group were signiﬁcantly
more frequently infected with STH than children within the fol-
lowed group (Table 3); 80% of the children diagnosed with STH
were lost to follow-up (p=0.010). We found no signiﬁcant differ-
ences between participants and losses to follow-up among all
other variables.
We investigated participants’ knowledge, attitudes and prac-
tices (KAP) with regard to schistosomiasis, geohelminths and
malaria and also behaviour regarding water, sanitation and
hygiene (WASH) at the baseline (Table 4). All children were
reported to have contact with dams, ponds, rivers or irrigation
canals, and 57.6% (114/197) of them had two or more contacts
per day and were infected with Schistosoma haematobium.
Water from those sources was reported to be used mainly for
bathing and playing. About 39.7% of the children were reported
to drink treated water, and they were signiﬁcantly infected with
Schistosoma haematobium (21.2%, p=0.001) and T. trichuria
(2.0%, p=0.001). It was noted that 34.0% of the households
had latrines; however, most latrine users had more Schistosoma
haematobium (50%) than STH infections, but the difference was
not signiﬁcant. Correct knowledge concerning Schistosoma hae-
matobium was signiﬁcant in 17.7% (p= 0.001) of participants
infected by the disease, of whom 20.7% (p=0.001) had already
urinated blood. Those that maintained contact with animals
were also more infected with Schistosoma haematobium
(22.7%, p=0.007).
Parasitological characteristics of the participants
At the baseline, 75.8% (150/198) of all children delivering urine
samples presented Schistosoma haematobium. From those,
10.8% were light, and 62.7% were heavy infections. Among
those providing faeces samples, 30.5% (60/197) were infected
with at least one STH, 13.7% (27/197) with A. lumbricoides,
14.7% (29/197) with T. trichiura and 5.1% (10/197) with hook-
worms. Other helminths identiﬁed at the baseline were H. nana
(10.2%, 20/197) and Strongyloides stercoralis (3.6%, 7/197).
Prevalence of malaria among children successfully delivering
blood samples was 6.9% (14/203).
Among the 67 children successfully completing the study of
helminths infections, the prevalence of Schistosoma haemato-
bium varied from 70.1% (47/67) to 53.7% (36/67) and 76.1%
(51/67) between the baseline, ﬁrst and second follow-up,
respectively. This corresponded to a 23.5% PRR between the
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baseline and ﬁrst follow-up (p=0.013), and to an increase of
prevalence either between the ﬁrst and second follow-up (PRR:
41.7%, p=0.003) but not between the baseline and second
follow-up (PRR: 8.6%, p=0.424).
At the same time, 77 children were submitted to malaria
RDT and the positive cases were treated by plasmodial infection.
The prevalence of malaria was 9.1% (7/77), 10.4% (8/77) and
2.6% (2/77) at the three time points of the study, respectively
(Table 5).
The intensity of Schistosoma haematobium infections, 1 mo
after the ﬁrst administration of praziquantel, was reduced by
86.9% (p<0.001), and heavy infections dropped from 62.7 to
34.3%. However, between the ﬁrst and second follow-ups, the
intensity of infection increased considerably (p<0.001). At all
evaluation time points, no heavy infections were observed for
either STH or H. nana. Moderate infections were only observed
for A. lumbricoides at the baseline, cleared after the ﬁrst admin-
istration of albendazole, and for T. trichiura 6 mo after
treatment.
We observed that some negative results in the baseline
became positive at the ﬁrst follow-up, namely, 6.0% (4/67) of
Schistosoma haematobium, 3.0% (2/67) of A. lumbricoides, 4.5%
(3/67) of T. trichiura, 1.5% (1/67) of hookworms, 1.5% (1/67) of
H. nana and 3.9% (3/77) of P. falciparum. Reinfections at the
second follow-up occurred only for Schistosoma haematobium
(85.7%, 12/14) and A. lumbricoides (33.3%, 1/3).
Prevalence of anaemia among all children presenting at the
baseline (Table 3) was 76.8% (159/207, CI: 70.5 to 82.4), of
which 66.7% (106/159, CI: 60.9 to 76.0) was moderate and
only 3.8% (6/159, CI: 1.4 to 8.3) was severe. Among the 67 chil-
dren who completed the all-infections study, 55.1% (37/67) had
anaemia (of which 14, 38 and 3% was mild, moderate and
severe, respectively). From the baseline to the second follow-up
period, a prevalence reduction of 25.9% (p=0.230), or 55.2 to
40.9%, was observed. In the analysis of the association
between anaemia and the infections studied (Table 4), we found
that moderate anaemia predominated. All cases of severe
anaemia (n=6, 3.0%) and most cases of moderate anaemia
Table 2. Exclusions and denominators used for prevalence estimation within evaluation time points
Time points Schistosoma
haematobium
Soil-transmitted
helminths (STH)
Hymenolepis nana Plasmodium falciparum Anaemia
Enrolled no. enrolled=209 no. enrolled=209 no. enrolled=209 no. enrolled=209 no. enrolled = 209
Baseline (0) 180 29 excluded 178 31 excluded 176 33 excluded 193 16 excluded 202 7 excluded
Evaluation -
treatment 2 no data
11 no urine 12 no faeces 12 no faeces 1 no data
5 invalid data13 missed PZQ 14 missed ALB 16 missed PZQ 10 previous
treatment
5 invalid data 5 invalid data 5 invalid data 5 invalid data
1 mo post-treatment
(1)
102 78 excluded 110 68 excluded 110 66 excluded 125 68 excluded 133 69 excluded
63 lost to
follow-up
17 no urine 8 no faeces 8 no faeces 62 lost to follow-
up
Evaluation (0)→(1)
6 invalid data
58 lost to
follow-up
55 lost to
follow-up
53 lost to
follow-up
6 invalid data
3 invalid data 5 invalid data 5 invalid data
6 mo post-treatment
(6a)
67 35 excluded 67 43 excluded 68 42 excluded 77 48 excluded 82 51 excluded
29 lost to
follow-up
5 no faeces 5 no faeces 44 lost to follow-
up
47 lost to
follow-up
Evaluation (1)→(6a) 6 invalid data 34 lost to
follow-up
34 lost to
follow-up
4 invalid data 4 invalid data
Treatment 4 invalid data 3 invalid data
6 mo post-treatment
(6b)
92 88 excluded 87 91 excluded 86 90 excluded 100 93 excluded 105 97 excluded
17 no urine 6 no faeces 6 no faeces 87 lost to follow-
up
91 lost to
follow-up
Evaluation (0)→(6b) 63 lost to
follow-up
82 lost to
follow-up
80 lost to
follow-up
6 invalid data 6 invalid data
Treatment 8 invalid data 3 invalid data 4 invalid data
ALB, albendazole; PZQ, praziquantel; (0), baseline; (1) 1 mo; (6a), 6 mo after ﬁrst treatment; (6b), 6 mo after baseline.
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(n=66, 33.3%) were infected with Schistosoma haematobium.
Infections by A. lumbricoide, H. nana and P. falciparum were not
found in any case of severe anaemia. We also veriﬁed that all
the severe cases occurred in the preschool-age children and
that they presented a slightly higher prevalence of anaemia
than the school-age children (73 vs 69%).
Approximately 52% of the participants reported transient
adverse events postmedication. The most mentioned were belly
pain, headache, dizziness and fatigue. No cases were taken to
the health facility.
Discussion
Previous cross-sectional studies conducted by CISA have already
reported a high prevalence of Schistosoma haematobium, STH,
H. nana and P. falciparum in children within this geographical
area of Angola.3 For the children who completed the protocol,
prevalence decreased in the ﬁrst month but rose again in the
sixth month, being similar to the baseline.
A high loss of follow-up was observed in this study (67%), a
situation common in many regions of Africa.18 However, the
families of dropout children recognised the beneﬁt of the study
and suggested that the research team move from house to house
advising families in order to improve adherence to the study.
Controlling infections with integrated doses of praziquantel and
albendazol resulted in a considerable egg reduction rate but a low
reduction in Schistosoma haematobium prevalence 1 mo after treat-
ment. Lee and coworkers19 performed a similar comprehensive
intervention with chemotherapy, health education and water supply,
and achieved a low reduction of Schistosoma haematobium preva-
lence of 13.5% after 6 mo of follow-up. At the same time, more
reduction was found in the village where there was a water supply.
Considering that during the duration of our study there was
no supply of drinkable water, those events may suggest a con-
tinuous contact with cercarial contaminated water. We
observed that almost a third of these children were highly
knowledgeable about the diseases and knew that the parasites
were caught in the collection of water and in the faeces or con-
taminated food, but they continued to go two or more times a
day to the irrigation canal, lake or pond to take baths and draw
water for domestic use. Although this suggests other strategies
of persuasion to provide adequate KAP,20 we did not see any
alternatives for them to obtain water of sufﬁcient quantity for
Table 3. Main characteristics of participants and dropouts in the study
Variables Baseline Participants (0→6) Lost to follow-up (0→6) p-value (participants
vs lost to follow-up)
Sex N=209 N=67 N=142
Male 110 (52.6%, CI: 45.6 to 60.0) 41 (37.3%, CI: 28.2 to 47.0) 69 (62.7%, CI: 53.0 to 71.8) 0.120
Female 99 (47.4%, CI: 40.4 to 54.4) 26 (26.3%, CI: 17.9 to 36.1) 73 (73.7%, CI: 63.9 to 82.1)
Age N=209 N=67 N=142
Median 6.0 6.0 6.0 0.382
Preschool age 93 (44.5%, CI: 37.6 to 51.5) 30 (32.3%, CI: 22.9 to 42.7) 63 (67.7%, CI: 57.3–77.1) 1.000
School age 116 (55.5%, CI: 48.5–62.4) 37 (31.9%, CI: 23.6–41.2) 79 (68.1%, CI: 58.8–76.4)
Attend school N=208 N=66 N=142
No 116 (55.8%, CI: 48.7 to 62.6) 40 (34.5%, CI: 25.9 to 43.9) 76 (65.5%, CI: 56.1 to 74.1) 0.419
Yes 92 (44.2%, CI: 37.4 to 51.3) 26 (28.3%, CI: 19.4 to 38.6) 66 (71.7%, CI: 61.4 to 80.6)
Schistosoma
haematobium
N=198 N=67 N=131
No 48 (24.2%, CI: 18.4 to 30.8) 20 (41.7%, CI: 27.6 to 56.8) 28 (58.3%, CI: 43.2 to 72.4) 0.254
Yes 150 (75.8%, CI: 69.2 to 81.6) 47 (31.3%, CI: 24.0 to 39.4) 103 (68.7%, CI: 60.6 to 76.0)
STH N=197 N=67 N=130
No 137 (69.5%, CI: 62.6 to 75.9) 55 (40.1%, CI: 31.9 to 48.9) 82 (59.9%, CI: 51.1 to 68.1) 0.010
Yes 60 (30.5%, CI: 24.1 to 37.4) 12 (20.0%, CI: 10.8 to 32.3) 48 (80.0%, CI: 67.7 to 89.2)
H. nana N=197 N=68 N=129
No 177 (89.8%, CI: 84.8 to 93.7) 59 (33.3%, CI: 26.4 to 40.8) 118 (66.7%, CI: 59.2 to 73.6) 0.428
Yes 20 (10.2%, CI: 6.3 to 15.2) 9 (45.0%, CI: 23.1 to 68.5) 11 (55.0%, CI: 31.5 to 76.9)
P. falciparum N=208 N=77 N=131
No 194 (93.3%, CI: 89.0 to 96.3) 70 (36.1%, CI: 29.3 to 43.3) 124 (63.9%, CI: 56.7 to 70.7) 0.450
Yes 14 (6.7%, CI: 3.7 to 11.0) 7 (50.0%, CI: 23.0 to 77.0) 7 (50.0%, CI: 23.0 to 77.0)
Anaemia N=207 N=82 N=125
No 48 (23.2%, CI: 17.6 to 29.5) 17 (35.4%, CI: 22.2 to 50.5) 31 (64.6%, CI: 49.5 to 77.8) 0.610
Yes 159 (76.8%, CI: 70.5 to 82.4) 65 (40.9%, CI: 33.2 to 48.9) 94 (59.1%, CI: 51.2 to 66.8)
STH, soil-transmitted helminths
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households, or to use only family or community latrines in order
to leave the main places where they become infected.We found
signiﬁcant associations of Schistosoma haematobium with
school-age children (p=0.013), drinking water (p=0.001), knowl-
edge, blood in urine and contact with animals (p=0.001) and A.
lumbricoides associated with girls (p=0.027).
Table 4. Baseline demographic and knowledge, attitudes and practices regarding infections
Characteristics Schistosoma
haematobium
A. lumbricoide T. trichuria Hookworms H. nana P. falciparum
n (%) p n (%) p n (%) p n (%) p n (%) p n (%) p
Overall 197 190 197 197 197 209
Demographic characteristics
Gender
Boys 77 (38.9) 0.274 8 (4.2) 0.027 17 (8.6) 0.092 1 (0.5) 0.297 12 (6.1) 0.058 104 (49.8) 0.448
Girls 73 (36.9) - 17 (8.9) - 8 (4.1) - 1 (0.5) - 4 (0.2) - 91 (43.5) -
Grouped age
Preschool-age children 57 (28.8) 0.013 12 (6.3) 0.522 8 (4.1) 0.209 1 (0.5) 0.447 9 (4.6) 0.289 89 (42.6) 0.214
School-age children 93 (47.0) - 13 (6.8) - 17 (8.6) - 3 (1.5) - 7 (3.6) - 106 (50.7) -
Water, sanitations and
hygiene practices (WASH)
Water contact
Once a day or less 36 (18.2) 0.317 7 (3.7) 0.837 6 (3.0) 0.818 1 (0.5) 0.967 2 (1.0) 0.202 4 (1.9) 0.741
Twice a day or more 114 (57.6) - 18 (9.5) - 19 (9.6) - 3 (1.5) - 14 (7.1) - 10 (4.8) -
Drinking treated water
(with lye, alum or boiling)
42 (21.2) 0.001 13 (6.8) 0.060 4 (2.0) 0.029 0 - 6 (3.0) 0.864 71 (36.0) 0.520
Use of latrine 99 (50.0) 0.335 22 (11.6) 0.996 16 (8.1) 0.996 4 (2.0) 0.129 9 (4.6) 0.503 7 (3.3) 0.221
Hand washing after
defecation
48 (24.2) 0.713 6 (3.2) 0.482 10 (5.1) 0.240 2 (1.0) 0.376 7 (3.6) 0.209) 7 (3.3) 0.103
Use of soap in hand
washing
19 (5.1) 0.528 3 (1.6) 0.154 1 (0.5) 0.712 0 - 0 - 0 -
Knowledge, attitude and
practices (KAP)
Knowledge of
schistosomiasis
35 (17.7) 0.001 8 (4.2) 0.947 7 (3.6) 0.029 1 (0.5) 0.186 5 (2.5) 0.975 4 (1.4) 0.226
Already urinated blood 41 (20.7) 0.001 11 (5.8) 0.538 11 (5.6) 0.630 1 (0.5) 0.547 7 (3.6) 0.723 6 (2.9) 0.774
Have been treated for
schistosomiasis
68 (34.3) 0.069 18 (9.5) 0.013 9 (4.6) 0.111 3 (1.5) 0.327 9 (4.6) 0.647 6 (2.9) 0.542
Knowledge of the
intestinal parasites
19 (9.6) 0.162 4 (2.1) 0.397 1 (0.5) 0.223 1 (0.5) 0.375 2 (1.0) 0.860 4 (1.9) 0.038
Already had blood in the
stool
103 (52.0) 0.162 18 (9.5) 0.862 17 (8.6) 0.672 3 (1.5) 0.878 12 (6.1) 0.751 10 (4.8) 0.943
Have been treated for STH 122 (61.6) 0.519 19 (10.0) 0,393 16 (8.1) 0.008 3 (1.5) 0.679 12 (6.1) 0.393 161 (77.0) 0.763
Usually have contact with
animals (dog, cat,
monkey)
45 (22.7) 0.007 5 (2.6) 0.478 8 (4.1) 0.539 1 (0.5) 0.931 3 (1.5) 0.443 2 (1.0) 0.209
Knowledge of malaria 9 (4.5) 0.629 2 (1.1) 0.612 0 - 1 (0.5) 0.088 0 - 9 (4.3) 0.118
They slept last night under
bednets
124 (62.6) 0.823 20 (10.5) 0.709 23 (11.7) 0.210 4 (2.0) 0.365 14 (7.1) 0.635 12 (5.7) 0.799
Anaemia
Mild 33 (16.7) 0.160 7 (3.7) - 6 (3.0) 0.194 0 - 6 (3.0) 0.104 2 (1.0) -
Moderate 66 (33.3) - 13 (6.8) - 15 (7.6) - 2 (1.0) - 3 (1.5) - 10 (4.8) -
Severe 6 (3.0) - 0 - 1 (0.5) - 1 (0.5) - 0 - 0 -
STH, soil-transmitted helminths
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Table 5. Effect of the intervention on the occurrence of the parasites in children completing the study
Indicators Schistosoma
haematobium (N=67)
STH (N=67) H. nana
(N=67)
P. falciparum
(N=77)
A. lumbricoides T. trichiura Hookworms
Baseline pretreatment (0)
No. of children infected 47 4 6 2 9 7
Prevalence: % (95% CI) 70.1 (57.7 to 80.7) 6.0 (1.7 to 14.6) 9.0 (3.4 to 18.5) 3.0 (0.4 to 10.4) 13.4 (6.2 to 23.6) 9.1 (3.7 to 17.8)
Infection level: % (95% CI)
Light 7.5 (2.5 to 16.6) 1.5 (0.0 to 8.0) 9.0 (3.4 to 18.5) 3.0 (0.4 to 10.4) 13.2 (6.2 to 23.6) -
Moderate - 4.5 (0.9 to 12.5) 0 0 0 -
Heavy 62.7 (41.3 to 87.5) 0 0 0 0 -
GM eggs count (95% CI) 498 (312 to 795) 4413 (11 to 13145) 168 (60 to 366) 55 (48 to 61) 93 (72 to 117) -
1 mo post-treatment (1)
No. of children infected 36 2 4 1 1 8
Prevalence: % (95% CI) 53.7 (41.1 to 66.0) 3.0 (0.4 to 10.4) 6.0 (1.7 to 14.6) 1.5 (0.0 to 8.0) 1.5 (0.0 to 7.9) 10.4 (4.6 to 19.4)
Infection level: % (95% CI)
Light 19.4 (10.8 to 30.9) 3.0 (0.4 to 10.4) 6.0 (1.7 to 14.6) 1.5 (0.0 to 8.0) 1.5 (0 to 7.9) -
Moderate - 0 0 0 0 -
Heavy 34.3 (23.2 to 46.5) 0 0 0 0 -
GM eggs count (95% CI) 65 (50 to 84) 51 (0 to 134) 269 (120 to 437) 243 243 -
PRR (0→1): % (p-value)¹ 23.5 (0.013) 50.0 (0.688) 33.3 (0.727) 50.0 (1.000) 88.6 (0.021) −14.3 (1.000)
ERR (0→1): % (p-value)2 86.9 (<0.001) 98.8 (0.356) 60 (0.626) - - -
New cases in % 6.0 (4/67) 3.0 (2/67) 4.5 (3/67) 1.5 (1/67) 1.5 (1/67) 3.9 (3/77)
6 mo post-treatment (6)
No. of children infected 51 3 2 0 8 2
Prevalence: % (95% CI) 76.1 (64.1 to 85.7) 4.5 (0.9 to 12.5) 3.0 (0.4 to 10.4) 0.0 (0.0 to 5.4) 11.9 (5.2 to 21.9) 2.6 (0.3 to 9.1)
Infection level: % (95% CI)
Light 11.9 (5.3 to 22.2) 4.5 (0.9 to 12.5) 1.5 (0.0 to 8.0) 0 11.8 (5.2 to 21.9) -
Moderate 0 1.5 (0.0 to 8.0) 0 0 -
Heavy 64.2 (42.5 to 89.2) 0 0 0 0 -
GM eggs count (95% CI) 252 (162 to 391) 477 (24 to 1320) 344 (192 to 509) 03 115 (86 to 150) -
PRR (1→6): % (p-value)¹ −41.7 (0.003) −50.0 (1.000) 50.0 (0.625) 100 −686.7 (0.039) 75.0 (0.109)
PRR (0→6): % (p-value)¹ −8.6 (0.424) 25.0 (1.000) 66.7 (0.289) 100 10.6 (1.000) 71.4 (0.180)
ERR (1→6): % (p-value)2 −287.2 (<0.001) −835.3 (0.357) 28.0 (0.626) - - -
ERR (0→6): % (p-value)2 49.4 (0.986) 89.2 (0.411) −104.8 - −23.7 (0,210) -
Reinfection in % 85.7 (12/14) 33.30 (1/3) 0.0 (0/5) 0.0 (0/2) 0.0 (0/9) 40.0 (2/5)
ERR, eggs reduction rate; GM, geometric mean of eggs count per 10 ml urine or 1 g of faeces in positive cases; PRR, prevalence reduction rate: (0→1) baseline to 1 mo, (1→6) 1
to 6 mo and (0→6) baseline to 6 mo after treatment.
¹McNemar test; 2paired sample t test; 3number of eggs.
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In addition, 1 mo after the integrated drug administration,
we observed a reduction in the prevalence of A. lumbricoides, T.
trichiura, hookworms and H. nana (only statistically signiﬁcant
for H. nana). Despite not being statistically signiﬁcant, the inten-
sity of infections in those children remaining infected with A.
lumbricoides and T. trichiura also decreased and moderate infec-
tions of A. lumbricoides were cleared, results that are concord-
ant with other studies showing that albendazole successfully
lowers the intensity of those infections.21,22 However, 3.0, 4.5,
1.5 and 1.5% of new A. lumbricoides, T. trichiura, hookworms
and H. nana infections were observed, respectively, suggesting
possible contact between children and contaminated environ-
ments, food and/or water between evaluation time points. This
hypothesis is reinforced by the reinfection rates observed for A.
lumbricoides and its consequent prevalence increase 6 mo after
treatment. Similarly, and despite no reinfection with H. nana
being observed at the end of the study, a signiﬁcant prevalence
increase was also veriﬁed for hymenolepiasis.
In the present study, it appears that both praziquantel and
albendazole presented some apparent failure or low effective-
ness in the treatment of the studied infections. A change in the
prescription pattern of praziquantel should also be considered,
as it was suggested that a single treatment regimen of prazi-
quantel may be unable to clear immature stages of
Schistosoma haematobium.21–23 Further investigation discrimin-
ating between reinfections and recurrent infections would help
clarify these matters. Additionally, it must also be considered
that a long prepatent period (approximately 6–8 wk) was
reported for Schistosoma haematobium, in which eggs may con-
tinue to be released from tissues, even after the clearance of
the worms.24 This could lead to the overestimation of positive
cases and thus inﬂuence the results presented here.
Further studies are recommended in the case of a modest
reduction in helminth infection observed after taking albenda-
zole drugs.25–27
Regarding P. falciparum, the prevalence increased from baseline
to ﬁrst follow-up, with 3.9% of new cases, but decreased after the
second follow-up, where 40% of reinfections were observed. This
prevalence variation is certainly associated with seasonality of
malaria risk since the ﬁrst follow-up was at the peak of the risk
season for malaria. The treatment of malaria was performed in
this study for ethical reasons and the evolution of its prevalence
was subject to several biases, such as seasonality. Moreover, the
distribution of bednet in the baseline could be a potential con-
founder when evaluating the effect of the intervention.
Prevalence of anaemia at the baseline, among the 67 children
who completed the study, was very high (82.0%). This prevalence
reduced, but not signiﬁcantly. All cases of anaemia were infected
with Schistosoma haematobium and this infection was the only
one found in cases of severe anaemia. In fact, A. lumbricoide, H.
nana and P. falciparum were not found in any severe case. We
attributed the strong inﬂuence of Schistosoma haematobium to the
occurrence or severity of anaemia, as described in other studies,
but other causes of anaemia were not investigated in this study.3
Participants in this study reported transient cases of medica-
tion side effects that usually occur with this type of intervention.28
A limitation of this study is the absence of some parasito-
logical examinations (that should be carried out on at least
three urine and faeces samples collected on different days),
which would allow a better estimation of the intensity of the
infection, also enabling the variability described in the excretion
of eggs during the day to be overcome. On the other hand,
recurrent infections and reinfections weren’t discriminated here.
In Angola, historical annual deworming with albendazole was
performed in schools and reported cases of haematuria were trea-
ted in health units. Consequently, a low therapeutic coverage was
reported regarding the goals recommended by WHO for the Africa
region.29 The strategic plan for neglected tropical diseases
2012–2015 included in the new National Sanitary Development
Plan already foresees the adoption of integrated preventive
chemotherapy with distribution of praziquantel, albendazole and
ivermectin in campaigns of deworming, to reach a therapeutic
coverage of 80–100% in school-age children and 70–95% in com-
munities between 2017–2021, in line with WHO recommenda-
tions.30 Thus, we believe that this study highlights some key
aspects that should be considered in order to maximise the effect-
iveness of future approaches in the Angolan context, such as the
strategy and monitoring of mass drug administration, environmen-
tal and health education for behavioural change, provision of
drinking water for hygiene and sanitation in communities.
Longitudinal studies have reported many losses in these set-
tings, but we were able to show that mass drug administration
for control of schistosomiasis and STH presents low effectiveness,
that reinfections occur rapidly and that stand alone anthelmintic
therapy is not a sustainable choice. In the context of our country,
drug effectiveness should be studied for its suitability.
Authors’ contributions: ML, SN, MB, HB and PS conceived and designed
the study. CM, ML, MB performed the experiments. ML, SM, CM, MB and
CF analyse the data and wrote the paper. All author read and approved
the ﬁnal manuscript.
Acknowledgements: We are especially grateful to all CISA technicians
for their outstanding contribution to this project. Susana Nery and
Miguel Brito acted as equivalent co-senior authors.
Funding: This work was supported by the promoters of the Centro de
Investigação em Saúde de Angola—Camões—Institute for Cooperation
and Language, Calouste Gulbenkian Foundation, Bengo Provincial
Government and the Ministry of Health of Angola, none of whom played
a role in either the design of the study or in interpreting the ﬁndings.
Competing interests: None declared.
Ethical approval: The authors assert that all procedures contributing to
this work comply with the ethical standards of the relevant national and
institutional committees on human experimentation and with the
Helsinki Declaration of 1975, as revised in 2008.
References
1 Hotez PJ, Brindley PJ, Bethony JM, et al. Helminth infections: the great
neglected tropical diseases. J Clin Invest. 2008;118(4):1311–21.
2 Herricks JR, Hotez PJ, Wanga V, et al. The global burden of disease
study 2013: What does it mean for the NTDs? PLoS Negl Trop Dis.
2017;11(8):e0005424.
International Health
93
D
ow
nloaded from
 https://academ
ic.oup.com
/inthealth/article-abstract/12/2/86/5530565 by guest on 19 February 2020
3 Sousa-Figueiredo JC, Gamboa D, Pedro JM, et al. Epidemiology of
malaria, schistosomiasis, geohelminths, anemia and malnutrition in
the context of a demographic surveillance system in northern
Angola. PLoS One. 2012;7(4):e33189.
4 Magalhães RJS, Langa A, Sousa-Figueiredo JC, et al. Finding malaria
hot-spots in northern Angola: the role of individual, household and
environmental factors within a meso-endemic area. Malar J. 2012;
11(1):385.
5 Schüle SA, Clowes P, Kroidl I, et al. Ascaris lumbricoides infection
and its relation to environmental factors in the Mbeya region of
Tanzania, a cross-sectional, population-based study. PLoS One.
2014;9(3):e92032.
6 Soares Magalhães RJ, Langa A, Pedro JM, et al. Role of malnutrition
and parasite infections in the spatial variation in children’s anaemia
risk in northern Angola. Geospatial Health. 2013;7(2):341–54.
7 Dickson R, Awasthi S, Williamson P, et al. Effects of treatment for
intestinal helminth infection on growth and cognitive performance
in children: systematic review of randomised trials. BMJ. 2000;320
(7251):1697–701.
8 Gyorkos TW, Gilbert NL, Larocque R, et al. Re-visiting Trichuris tri-
chiura intensity thresholds based on anemia during pregnancy. PLoS
Negl Trop Dis. 2012;6(9):e1783.
9 Lewis FA, Tucker MS. Schistosomiasis. New York, NY: Springer; 2014,
47–75.
10 João Costa M, Rosário E, Langa A, et al. Setting up a demographic
surveillance system in northern Angola. Afr Popul Stud. 2012;26(2):
133–146.
11 World Health Organization. Manual of basic techniques for a health
laboratory, 2nd ed. Geneva, Switzerland: World Health Organization;
2003.
12 Mirante C, Clemente I, Zambu G, et al. Comparing concentration
methods: parasitrap® versus Kato-Katz for studying the prevalence
of Helminths in Bengo province, Angola. Afr Health Sci. 2016;16(3):
698–703.
13 Moonen B, Cohen JM, Snow RW, et al. Operational strategies to
achieve and maintain malaria elimination. Lancet. 2010;376(9752):
1592–1603.
14 Chen I, Clarke SE, Gosling R, et al. ‘Asymptomatic’ malaria: a chronic
and debilitating infection that should be treated. PLoS Med. 2016;13
(1):e1001942.
15 World Health Organization. Basic laboratory methods in medical
parasitology. Geneva, Switzerland: World Health Organization; 1991.
16 Ahmed AM, Abbas H, Mansour FA, et al. Schistosoma haematobium
infections among schoolchildren in central Sudan one year after
treatment with praziquantel. Parasit Vectors. 2012;5(1):108.
17 Montresor A, Crompton DWT, Hall A, et al. Guidelines for the evalu-
ation of soil-transmitted helminthiasis and schistosomiasis at com-
munity level : a guide for managers of control. WHO/CTD/SIP/98.1
programmes. 1998. http://apps.who.int/iris/handle/10665/63821
(Accessed January 12 2019).
18 Saathoff E, Olsen A, Kvalsvig JD, et al. Patterns of geohelminth infec-
tion, impact of albendazole treatment and re-infection after treat-
ment in schoolchildren from rural KwaZulu-Natal/South-Africa. BMC
Infect Dis. 2004;4(1):27.
19 Lee Y-H, Jeong HG, Kong WH, et al. Reduction of urogenital schisto-
somiasis with an integrated control project in Sudan. PLoS Negl Trop
Dis. 2015;9(1):e3423.
20 Sady H, Al-Mekhlaﬁ HM, Atroosh WM, et al. Knowledge, attitude, and
practices towards schistosomiasis among rural population in Yemen.
Parasit Vectors. 2015;8(1):436.
21 Tchuem Tchuenté L-A, Momo SC, Stothard JR, et al. Efﬁcacy of prazi-
quantel and reinfection patterns in single and mixed infection foci
for intestinal and urogenital schistosomiasis in Cameroon. Acta Trop.
2013;128(2):275–83.
22 Tchuenté L-AT, Shaw DJ, Polla L, et al. Efﬁcacy of praziquantel
against Schistosoma haematobium infection in children. Am J Trop
Med Hyg. 2004;71(6):778–82.
23 Botros S, Pica-Mattoccia L, William S, et al. Effect of praziquantel on
the immature stages of Schistosoma haematobium. Int J Parasitol.
2005;35(13):1453–7.
24 Loker ES. A comparative study of the life-histories of mammalian
schistosomes. Parasitology. 1983;87(Pt 2):343–69.
25 Newton S, Terryah S, Boakye D, et al. Hookworm infection among
school age children in Kintampo north municipality, Ghana: nutri-
tional risk factors and response to albendazole treatment. Am J Trop
Med Hyg. 2013;89(3):540–8.
26 Prichard RK, Basáñez M-G, Boatin BA, et al. A research agenda for
helminth diseases of humans: intervention for control and elimin-
ation. PLoS Negl Trop Dis. 2012;6(4):e1549.
27 Vercruysse J, Albonico M, Behnke JM, et al. Is anthelmintic resistance
a concern for the control of human soil-transmitted helminths? Int J
Parasitol Drugs Drug Resist. 2011;1(1):14–27.
28 Samuel F, Demsew A, Alem Y, et al. Soil transmitted helminthiasis
and associated risk factors among elementary school children
in Ambo town, western Ethiopia. BMC Public Health. 2017;17(1):791.
29 World Health Organization. WHO country report 2010 Angola. 2010.
https://www.who.int/countries/ago/en/ (Accessed January 12 2019).
30 Utzinger J, Brattig NW, Kristensen TK. Schistosomiasis research in
Africa: how the CONTRAST alliance made it happen. Acta Trop. 2013;
128(2):182–95.
M. Lemos et al.
94
D
ow
nloaded from
 https://academ
ic.oup.com
/inthealth/article-abstract/12/2/86/5530565 by guest on 19 February 2020
